- Home
- DXR vs BSIN Comparison
DXR vs BSIN Comparison
Compare DXR & BSIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$11.45
Company Overview
Basic Information| Metric | DXR | BSIN |
|---|---|---|
| Founded | 1970 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.0M | 53.4M |
| IPO Year | 1995 | 1995 |
Fundamental Metrics
Financial Performance| Metric | DXR | BSIN |
|---|---|---|
| Price | $11.45 | $1.57 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 40.0K | ★ 833.4K |
| Earning Date | 02-27-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.21 |
| EPS | ★ N/A | N/A |
| Revenue | $1,446,345.00 | ★ $32,379,000.00 |
| Revenue This Year | $44,935.22 | N/A |
| Revenue Next Year | $74.79 | N/A |
| P/E Ratio | $33.83 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.56 | $1.00 |
| 52 Week High | $14.76 | $1.67 |
Technical Indicators
Market Signals| Indicator | DXR | BSIN |
|---|---|---|
| Relative Strength Index (RSI) | 59.61 | 59.60 |
| Support Level | $9.43 | $1.44 |
| Resistance Level | $12.08 | $1.62 |
| Average True Range (ATR) | 0.76 | 0.07 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 65.96 | 71.74 |
Price Performance
Historical Comparison DXR
BSIN
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.